As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and ...

Shares of Regeneron Pharmaceuticals Inc. slipped 4.06% to $634.14 Tuesday, on what proved to be an all-around favorable ...

Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House ...

Insiders who purchased Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS ) shares in the past 12 months are unlikely to ...

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC ...

Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the ...

Avantax Advisory Services Inc. acquired a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 2,140 ...

Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Nuvectis Pharma, Inc.’s NVCT share price has dipped by 11.52%, which has investors questioning if this is right time to buy.

NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...